Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-14

Clinical Trial Update: Repurposing Lithium for Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 study investigating repurposing lithium for Parkinson's disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium (Lithium carbonate)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2026-04-14